Goldman Sachs’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-111,861
| Closed | -$130K | – | 6857 |
|
|
2022
Q2 | $130K | Buy |
111,861
+19,269
| +21% | +$20.1K | ﹤0.01% | 5786 |
|
|
2022
Q1 | $100K | Sell |
92,592
-15,786
| -15% | -$11.9K | ﹤0.01% | 6110 |
|
|
2021
Q4 | $78K | Buy |
108,378
+69,108
| +176% | +$55.9K | ﹤0.01% | 6186 |
|
|
2021
Q3 | $35K | Sell |
39,270
-5,700
| -13% | -$6.86K | ﹤0.01% | 6105 |
|
|
2021
Q2 | $75K | Sell |
44,970
-48,378
| -52% | -$80.9K | ﹤0.01% | 6015 |
|
|
2021
Q1 | $195K | Buy |
93,348
+80,082
| +604% | +$166K | ﹤0.01% | 5658 |
|
|
2020
Q4 | $17K | Sell |
13,266
-73,913
| -85% | -$88.2K | ﹤0.01% | 5442 |
|
|
2020
Q3 | $106K | Sell |
87,179
-6,639
| -7% | -$8.07K | ﹤0.01% | 5080 |
|
|
2020
Q2 | $110K | Sell |
93,818
-6,716
| -7% | -$6.21K | ﹤0.01% | 4970 |
|
|
2020
Q1 | $82K | Sell |
100,534
-50,425
| -33% | -$53.5K | ﹤0.01% | 4976 |
|
|
2019
Q4 | $152K | Sell |
150,959
-107,623
| -42% | -$130K | ﹤0.01% | 4972 |
|
|
2019
Q3 | $365K | Buy |
258,582
+247,009
| +2,134% | +$349K | ﹤0.01% | 4593 |
|
|
2019
Q2 | $17K | Buy |
+11,573
| New | +$17.9K | ﹤0.01% | 5065 |
|
|
2018
Q4 | – | Sell |
-65,818
| Closed | -$120K | – | 5823 |
|
|
2018
Q3 | $120K | Buy |
65,818
+45,181
| +219% | +$87.6K | ﹤0.01% | 5077 |
|
|
2018
Q2 | $38K | Buy |
+20,637
| New | +$38.4K | ﹤0.01% | 5415 |
|
|
2016
Q3 | – | Sell |
-45,443
| Closed | -$37K | – | 7249 |
|
|
2016
Q2 | $37K | Buy |
45,443
+11,332
| +33% | +$8.78K | ﹤0.01% | 6524 |
|
|
2016
Q1 | $31K | Buy |
34,111
+1,464
| +4% | +$1.47K | ﹤0.01% | 6612 |
|
|
2015
Q4 | $36K | Sell |
32,647
-36,107
| -53% | -$77.3K | ﹤0.01% | 6688 |
|
|
2015
Q3 | $145K | Sell |
68,754
-2,251
| -3% | -$4.39K | ﹤0.01% | 6234 |
|
|
2015
Q2 | $141K | Buy |
+71,005
| New | +$201K | ﹤0.01% | 6421 |
|
|
2014
Q4 | – | Sell |
-16,711
| Closed | -$44K | – | 7382 |
|
|
2014
Q3 | $44K | Buy |
16,711
+4,200
| +34% | +$28.1K | ﹤0.01% | 6859 |
|
|
2014
Q2 | $145K | Buy |
+12,511
| New | +$142K | ﹤0.01% | 6398 |
|
Goldman Sachs's MBII Position: Q3 2022 in Review
Goldman Sachs sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 111,861 shares — an estimated $130K sold.
Goldman Sachs first reported a position in MBII in Q2 2014 and held it in 22 quarters. The position peaked at $365K in Q3 2019. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- Goldman Sachs reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- Goldman Sachs sold 111,861 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $130K.
- Goldman Sachs first reported a position in Marrone Bio Innovations, Inc. in Q2 2014 and held it in 22 quarters.
- Goldman Sachs's Marrone Bio Innovations, Inc. position peaked at $365K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.